Rob Kim, based in Saint Paul, MN, US, is currently a Oncology Executive Therapeutic Specialist - Trodelvy (sacituzumab govitecan) at Gilead Sciences. Rob Kim brings experience from previous roles at Immunomedics, Genentech and GlaxoSmithKline. Rob Kim holds a University of Cincinnati College of Business. Rob Kim has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Rob Kim?
Find contact details for 700 million professionals.